REG - Elixirr Intnl PLC - Director Declaration
ELIXIRR INTERNATIONAL PLC
("Elixirr", the "Company" or the "Group")
Director Declaration
Elixirr International plc (AIM:ELIX), the established, global award-winning challenger consultancy, has been notified by Simon Retter, Non-Executive Director of the Company, that Horizonte Minerals plc, a company of which he was a Director until 25 November 2023, entered administration on 16 May 2024.
This announcement is made in accordance with AIM Rule 17 and Schedule Two, paragraph (g) of the AIM Rules for Companies.
For further information please contact:
Elixirr International plc Stephen Newton, CEO Graham Busby, CFO | ||||
Public and Investor Relations contacts: investor-relations@elixirr.com Cavendish Capital Markets Ltd (Nominated Adviser & Joint Broker) Stephen Keys, Charlie Beeson (Corporate Finance) Sunila de Silva (Corporate Broking) Investec Bank plc (Joint Broker) Carlton Nelson, Henry Reast (Corporate Broking) | +44 (0) 20 7220 0500 +44 (0) 20 7597 4000 | |||
About Elixirr International plc
Elixirr is an established global award-winning management consultancy, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally-recognised client base.
Elixirr was founded in 2009, by Stephen Newton, Graham Busby, Ian Ferguson, Andy Curtis and Mark Goodyear, experienced business advisors who identified a market opportunity to provide bespoke, personal services as a 'challenger' to the traditional consultancy businesses in the market. Elixirr guides its clients to overcome challenges such as: future-proofing against technological disruption; development and roll-out of new propositions, products and services; incubating new businesses; navigating a more complex and multinational regulatory environment; and project management and implementation of major change programmes.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END RDNMZGZKVMNGDZM